DOI QR코드

DOI QR Code

Impact of Multivessel Coronary Disease With Chronic Total Occlusion on One-Year Mortality in Patients With Acute Myocardial Infarction

  • Lee, Ju-Hwan (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Hun-Sik (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Ryu, Hyeon-Min (Department of Internal Medicine, Gumi CHA Hospital) ;
  • Lee, Hyun-Sang (Department of Internal Medicine, Gumi CHA Hospital) ;
  • Bae, Myung-Hwan (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Lee, Jang-Hoon (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Yang, Dong-Heon (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Cho, Yong-Keun (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Jun, Jae-Eun (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • Published : 2012.02.29

Abstract

Background and Objectives: The impact of multivessel coronary disease (MVD) with chronic total occlusion (CTO) on one-year mortality in patients with acute myocardial infarction (AMI) is not clearly known. We investigated the impact of MVD with concurrent CTO lesion on one-year mortality in patients with AMI. Subjects and Methods: We studied 1008 consecutive patients who underwent coronary angiography between November 2005 and December 2008 with a diagnosis of AMI. Results: Among 1008 patients, 432 patients (43%) had MVD, and 88 patients (8.7%) had CTO lesion. The one-year overall mortality was higher in patients with MVD than in patients with single vessel disease (SVD) (10.2% vs. 5.9%, p=0.012). However, the one-year overall mortality was not significantly higher in patients with CTO lesion than in patients without that lesion (12.5% vs. 7.3%, p=0.080). In multivariate analysis, independent predictors of one-year overall mortality were age older than 65 years {hazard ratio (HR) 2.41, 95% confidence interval (CI): 1.43 to 4.08}, Killip class ${\geq}$III (HR 3.59, 95% CI: 2.24 to 5.77), ST-elevation myocardial infarction (HR 2.45, 95% CI: 1.49 to 4.05) and MVD (HR 1.76, 95% CI: 1.07 to 2.89). Conclusion: Patients with MVD showed higher one-year mortality than patients with SVD. However, the presence of CTO was not an independent predictor of one-year mortality in this study that included patients with successfully revascularized CTO lesion.

Keywords

References

  1. O' Keefe JH Jr, Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-30. https://doi.org/10.1016/0002-9149(89)90558-4
  2. Moreno R, García E, Soriano J, et al. Early coronary angioplasty for acute myocardial infarction: predictors of poor outcome in a non-selected population. J Invasive Cardiol 2001;13:202-10.
  3. van der Schaaf RJ, Timmer YR, Ottervanger JP, et al. Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart 2006; 92:1760-3. https://doi.org/10.1136/hrt.2005.086058
  4. De Boer MJ, Suryapranata H, Hoorntje JC, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61. https://doi.org/10.1161/01.CIR.90.2.753
  5. Shihara M, Tsutsui H, Tsuchihashi M, Tada H, Kono S, Takeshita A; Japanese Coronary Invention Study (JCIS) Group. In-hospital and oneyear outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2002;90:932-6. https://doi.org/10.1016/S0002-9149(02)02656-5
  6. Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart 2005;91:1541-4. https://doi.org/10.1136/hrt.2004.054692
  7. Waldecker B, Wass W, Haberbosch W, Voss R, Heizmann H, Tillmanns H. Long-term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32:1320-5. https://doi.org/10.1016/S0735-1097(98)00405-7
  8. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effects of chronic total coronary occlusion on treatment strategy. Am J Cardiol 2005;95:1088-91. https://doi.org/10.1016/j.amjcard.2004.12.065
  9. van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol 2006;98:1165-9. https://doi.org/10.1016/j.amjcard.2006.06.010
  10. Claessen BE, Hoebers LP, van der Schaaf RJ, et al. Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on longterm mortality in diabetic patients with ST elevation myocardial infarction. Heart 2010;96:1968-72. https://doi.org/10.1136/hrt.2010.197673
  11. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99-106. https://doi.org/10.1136/heart.90.1.99
  12. Claessen BE, van der Schaaf RJ, Verouden NJ, et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovsc Interv 2009;2:1128-34. https://doi.org/10.1016/j.jcin.2009.08.024
  13. Schomig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005; 293:2865-72. https://doi.org/10.1001/jama.293.23.2865
  14. Piscione F, Galasso G, De Luca G, et al. Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome. Heart 2005;91:646-51. https://doi.org/10.1136/hrt.2004.041152
  15. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and longterm survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001;38:409-14. https://doi.org/10.1016/S0735-1097(01)01349-3
  16. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. Eur Heart J 2005;26:2630-6. https://doi.org/10.1093/eurheartj/ehi498
  17. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J 2010;160:179-87. https://doi.org/10.1016/j.ahj.2010.04.015

Cited by

  1. Predictors and Clinical Implications of Minimal ST-Segment Elevation in Patients with ST-Segment Elevation Myocardial Infarction vol.128, pp.3, 2012, https://doi.org/10.1159/000362438
  2. Association of red cell distribution width with noninfarct-related artery-chronic total occlusion in acute myocardial infarction patients vol.11, pp.3, 2012, https://doi.org/10.2217/bmm-2016-0255
  3. The 11-Year Prognostic Impact of Chronic Total Occlusion in the Noninfarct-Related Coronary Artery on Patients with Acute Myocardial Infarction vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/6646804